Osaic Holdings
SLS icon

Osaic Holdings’s SELLAS Life Sciences SLS Stock Holding History

Osaic Holdings’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$200K Buy
47,272
+23,583
+100% +$106K ﹤0.01% 4137
2025
Q4 		$89.3K Buy
23,689
+16,029
+209% +$31.2K ﹤0.01% 4806
2025
Q3 		$14.7K Hold
7,660
– – ﹤0.01% 6131
2025
Q2 		$16.8K Buy
7,660
+5,000
+188% +$7.67K ﹤0.01% 5838
2025
Q1 		$2.87K Buy
2,660
+1,000
+60% +$1.19K ﹤0.01% 6452
2024
Q4 		$1.73K Hold
1,660
– – ﹤0.01% 6661
2024
Q3 		$2.08K Hold
1,660
– – ﹤0.01% 6595
2024
Q2 		$1.98K Hold
1,660
– – ﹤0.01% 6598
2024
Q1 		$1.68K Hold
1,660
– – ﹤0.01% 6537
2023
Q4 		$1.76K Sell
1,660
-1,660
-50% -$1.8K ﹤0.01% 6579
2023
Q3 		$5.44K Buy
3,320
+1,660
+100% +$2.62K ﹤0.01% 6231
2023
Q2 		$2.61K Hold
1,660
– – ﹤0.01% 6570
2023
Q1 		$2.37K Hold
1,660
– – ﹤0.01% 6645
2022
Q4 		$4K Sell
1,660
-5
-0.3% -$14 ﹤0.01% 6426
2022
Q3 		$3K Sell
1,665
-200
-11% -$552 ﹤0.01% 6662
2022
Q2 		$4K Buy
1,865
+1,000
+116% +$2.93K ﹤0.01% 6628
2022
Q1 		$5K Hold
865
– – ﹤0.01% 6501
2021
Q4 		$5K Sell
865
-1,215
-58% -$9.19K ﹤0.01% 6654
2021
Q3 		$19K Buy
2,080
+500
+32% +$4.64K ﹤0.01% 5825
2021
Q2 		$17K Buy
1,580
+205
+15% +$2K ﹤0.01% 5763
2021
Q1 		$11K Buy
1,375
+1,065
+344% +$8.71K ﹤0.01% 5830
2020
Q4 		$2K Buy
310
+150
+94% +$600 ﹤0.01% 6105
2020
Q3 		$0 Hold
160
– – ﹤0.01% 6388
2020
Q2 		$0 Hold
160
– – ﹤0.01% 6305
2020
Q1 		$0 Buy
+160
New +$412 ﹤0.01% 6169

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Osaic Holdings's SLS Position: Q1 2026 in Review

Osaic Holdings increased its SELLAS Life Sciences (SLS) stake by 100% in Q1 2026, buying an estimated $106K and bringing the position to 47,272 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #4137.

Osaic Holdings first reported a position in SLS in Q1 2020 and has held it in 25 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Osaic Holdings held 47,272 shares of SELLAS Life Sciences worth $200K as of Q1 2026.
  • Osaic Holdings bought 23,583 SELLAS Life Sciences shares in Q1 2026, an estimated $106K.
  • SELLAS Life Sciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4137 holding.
  • Osaic Holdings first reported a position in SELLAS Life Sciences in Q1 2020 and has held it in 25 quarters since.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.